Mots-c 10mg

MOTS-C 10mg Research Vial

The Driada Medical MOTS-C 10mg Research Vial is manufactured to high purity standards and supplied exclusively for laboratory and scientific research applications.

Each vial contains 10mg of research-grade MOTS-C, produced under strict quality control to ensure consistency, purity, and reliability for qualified research professionals.

Product Specifications

Compound: MOTS-C

Strength: 10mg

Format: Lyophilised Powder

Purity: ≥99%

Storage: Store refrigerated at 2–8°C. Do not freeze.

Research Use Only

Package Contents
1 × MOTS-C 10mg Research Vial
1 × 1ml Bacteriostatic Water

Important Notice

This product is supplied strictly for laboratory and scientific research purposes only. It is not intended for human or veterinary use, diagnosis, treatment, or prevention of any disease.

Purchasers are responsible for ensuring compliance with all applicable laws and regulations in their jurisdiction.

ℹ️ℹ️ℹ️ℹ️

What it is: MOTS-c

(Mitochondrial Open Reading Frame of the 12S rRNA-c) is a naturally occurring peptide produced by mitochondria. It is being researched for its potential effects on metabolism, exercise performance, aging, and insulin sensitivity.

Storage Instructions

Before Mixing (Powder):

Store unopened vials at room temperature (below 25°C / 77°F) or in the refrigerator (2°C to 8°C). Protect the powder from direct light and do not freeze.

After Mixing (Solution):

Mixed medication should be refrigerated  immediately. 

What it does (based on current research):

Improves insulin sensitivity.

Helps regulate glucose (blood sugar) metabol

Increases fat utilization and energy production.

Improves exercise capacity and endurance in some studies.

Supports metabolic health and healthy aging.

Benefits:

Improved metabolic function.

Better blood sugar control.

Increased energy and exercise performance.

Possible support for weight management.

Potential anti-aging effects.

Possible side effects: Human safety data are limited. Reported or possible side effects include:

Injection site pain, redness, or swelling.

Headache.

Nausea.

fatigue.

Dizziness.

Changes in blood sugar (especially in people taking diabetes medications).

Allergic reactions are possible but uncommon.

How it is used:

MOTS-c is typically administered by subcutaneous injection in research or wellness settings. There is no standardized or FDA-approved dosing regimen, and products sold online may vary in quality and purity.

Who should avoid or use caution:

Pregnant or breastfeeding individuals.

Children.

People with diabetes or those taking blood sugar-lowering medications (unless supervised by a healthcare professional).

Anyone with significant medical conditions should consult their healthcare provider before use.

#motc #mitochondrialpeptide #driadamedical #peptides #research #researchuseonly #laboratoryresearch #mot